vs
Freshpet, Inc.（FRPT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Freshpet, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$285.2M vs $207.3M），Freshpet, Inc.净利率更高（11.9% vs -62.0%，领先73.9%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 8.6%），Freshpet, Inc.自由现金流更多（$2.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 12.9%）
Freshpet, Inc.是一家美国宠物食品企业，主打鲜制猫粮、狗粮产品，相关产品需冷藏保存，目前在纳斯达克上市，股票代码为FRPT。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
FRPT vs RARE — 直观对比
营收规模更大
FRPT
是对方的1.4倍
$207.3M
营收增速更快
RARE
高出17.3%
8.6%
净利率更高
FRPT
高出73.9%
-62.0%
自由现金流更多
FRPT
多$102.8M
$-100.8M
两年增速更快
RARE
近两年复合增速
12.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $285.2M | $207.3M |
| 净利润 | $33.8M | $-128.6M |
| 毛利率 | 43.3% | — |
| 营业利润率 | 15.6% | -54.7% |
| 净利率 | 11.9% | -62.0% |
| 营收同比 | 8.6% | 25.9% |
| 净利润同比 | 86.6% | 3.5% |
| 每股收益（稀释后） | $0.71 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FRPTRARE
| Q4 25 | $285.2M | $207.3M | ||
| Q3 25 | $288.8M | $159.9M | ||
| Q2 25 | $264.7M | $166.5M | ||
| Q1 25 | $263.2M | $139.3M | ||
| Q4 24 | $262.7M | $164.6M | ||
| Q3 24 | $253.4M | $139.5M | ||
| Q2 24 | $235.3M | $147.0M | ||
| Q1 24 | $223.8M | $108.8M |
净利润FRPTRARE
| Q4 25 | $33.8M | $-128.6M | ||
| Q3 25 | $101.7M | $-180.4M | ||
| Q2 25 | $16.4M | $-115.0M | ||
| Q1 25 | $-12.7M | $-151.1M | ||
| Q4 24 | $18.1M | $-133.2M | ||
| Q3 24 | $11.9M | $-133.5M | ||
| Q2 24 | $-1.7M | $-131.6M | ||
| Q1 24 | $18.6M | $-170.7M |
毛利率FRPTRARE
| Q4 25 | 43.3% | — | ||
| Q3 25 | 39.5% | — | ||
| Q2 25 | 40.9% | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.5% | — | ||
| Q3 24 | 40.4% | — | ||
| Q2 24 | 39.9% | — | ||
| Q1 24 | 39.4% | — |
营业利润率FRPTRARE
| Q4 25 | 15.6% | -54.7% | ||
| Q3 25 | 8.6% | -106.9% | ||
| Q2 25 | 6.7% | -64.8% | ||
| Q1 25 | -4.4% | -102.6% | ||
| Q4 24 | 7.4% | -74.3% | ||
| Q3 24 | 4.7% | -94.6% | ||
| Q2 24 | -0.7% | -79.1% | ||
| Q1 24 | 3.8% | -151.9% |
净利率FRPTRARE
| Q4 25 | 11.9% | -62.0% | ||
| Q3 25 | 35.2% | -112.8% | ||
| Q2 25 | 6.2% | -69.0% | ||
| Q1 25 | -4.8% | -108.5% | ||
| Q4 24 | 6.9% | -80.9% | ||
| Q3 24 | 4.7% | -95.7% | ||
| Q2 24 | -0.7% | -89.5% | ||
| Q1 24 | 8.3% | -156.8% |
每股收益（稀释后）FRPTRARE
| Q4 25 | $0.71 | $-1.28 | ||
| Q3 25 | $1.86 | $-1.81 | ||
| Q2 25 | $0.33 | $-1.17 | ||
| Q1 25 | $-0.26 | $-1.57 | ||
| Q4 24 | $0.35 | $-1.34 | ||
| Q3 24 | $0.24 | $-1.40 | ||
| Q2 24 | $-0.03 | $-1.52 | ||
| Q1 24 | $0.37 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $278.0M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $-80.0M |
| 总资产 | $1.8B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FRPTRARE
| Q4 25 | $278.0M | $421.0M | ||
| Q3 25 | $274.6M | $202.5M | ||
| Q2 25 | $243.7M | $176.3M | ||
| Q1 25 | $243.7M | $127.1M | ||
| Q4 24 | $268.6M | $174.0M | ||
| Q3 24 | $274.6M | $150.6M | ||
| Q2 24 | $251.7M | $480.7M | ||
| Q1 24 | $257.9M | $112.3M |
股东权益FRPTRARE
| Q4 25 | $1.2B | $-80.0M | ||
| Q3 25 | $1.2B | $9.2M | ||
| Q2 25 | $1.1B | $151.3M | ||
| Q1 25 | $1.0B | $144.2M | ||
| Q4 24 | $1.1B | $255.0M | ||
| Q3 24 | $1.0B | $346.8M | ||
| Q2 24 | $995.8M | $432.4M | ||
| Q1 24 | $977.8M | $140.3M |
总资产FRPTRARE
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.5B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $2.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 0.7% | -48.6% |
| 资本支出强度资本支出/营收 | 18.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.63× | — |
| 过去12个月自由现金流最近4个季度 | $12.4M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流FRPTRARE
| Q4 25 | $55.1M | $-99.8M | ||
| Q3 25 | $66.8M | $-91.4M | ||
| Q2 25 | $33.9M | $-108.3M | ||
| Q1 25 | $4.8M | $-166.5M | ||
| Q4 24 | $50.4M | $-79.3M | ||
| Q3 24 | $56.1M | $-67.0M | ||
| Q2 24 | $42.4M | $-77.0M | ||
| Q1 24 | $5.4M | $-190.7M |
自由现金流FRPTRARE
| Q4 25 | $2.1M | $-100.8M | ||
| Q3 25 | $31.6M | $-92.7M | ||
| Q2 25 | $445.0K | $-110.7M | ||
| Q1 25 | $-21.7M | $-167.8M | ||
| Q4 24 | $-7.9M | $-79.5M | ||
| Q3 24 | $22.1M | $-68.6M | ||
| Q2 24 | $-5.9M | $-79.0M | ||
| Q1 24 | $-41.1M | $-193.9M |
自由现金流率FRPTRARE
| Q4 25 | 0.7% | -48.6% | ||
| Q3 25 | 10.9% | -58.0% | ||
| Q2 25 | 0.2% | -66.5% | ||
| Q1 25 | -8.2% | -120.5% | ||
| Q4 24 | -3.0% | -48.3% | ||
| Q3 24 | 8.7% | -49.2% | ||
| Q2 24 | -2.5% | -53.7% | ||
| Q1 24 | -18.3% | -178.2% |
资本支出强度FRPTRARE
| Q4 25 | 18.6% | 0.5% | ||
| Q3 25 | 12.2% | 0.8% | ||
| Q2 25 | 12.6% | 1.5% | ||
| Q1 25 | 10.1% | 1.0% | ||
| Q4 24 | 22.2% | 0.1% | ||
| Q3 24 | 13.4% | 1.2% | ||
| Q2 24 | 20.5% | 1.4% | ||
| Q1 24 | 20.8% | 3.0% |
现金转化率FRPTRARE
| Q4 25 | 1.63× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 2.07× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.78× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRPT
| Sales Channel Grocery Mass International And Digital | $228.4M | 80% |
| Sales Channel Pet Specialty And Club | $56.8M | 20% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
